Alberto Piubello

2.1k total citations
28 papers, 584 citations indexed

About

Alberto Piubello is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Alberto Piubello has authored 28 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 17 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Alberto Piubello's work include Tuberculosis Research and Epidemiology (23 papers), Pneumonia and Respiratory Infections (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Alberto Piubello is often cited by papers focused on Tuberculosis Research and Epidemiology (23 papers), Pneumonia and Respiratory Infections (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Alberto Piubello collaborates with scholars based in Belgium, France and Niger. Alberto Piubello's co-authors include Armand Van Deun, Mahamadou Bassirou Souleymane, Tom Decroo, Hans L. Rieder, Christopher Kuaban, J Noeske, Arnaud Trébucq, V Schwoebel, Kobto G. Koura and Bouke C. de Jong and has published in prestigious journals such as PLoS Medicine, European Respiratory Journal and Respiratory Medicine.

In The Last Decade

Alberto Piubello

25 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Piubello Belgium 12 537 424 181 50 36 28 584
Xavier Padanilam South Africa 11 669 1.2× 531 1.3× 221 1.2× 63 1.3× 32 0.9× 17 732
Lorenzo Guglielmetti France 14 483 0.9× 457 1.1× 187 1.0× 72 1.4× 13 0.4× 42 653
Anja Reuter South Africa 13 400 0.7× 276 0.7× 114 0.6× 61 1.2× 17 0.5× 31 469
Elizabeth Harausz United States 7 332 0.6× 249 0.6× 120 0.7× 80 1.6× 23 0.6× 11 413
Ronelle Moodliar United Kingdom 4 362 0.7× 258 0.6× 127 0.7× 40 0.8× 19 0.5× 7 403
Carl Reddy South Africa 9 474 0.9× 379 0.9× 129 0.7× 117 2.3× 56 1.6× 15 602
Paul Daru Bangladesh 5 510 0.9× 406 1.0× 185 1.0× 65 1.3× 30 0.8× 10 550
Grania Brigden United States 12 362 0.7× 268 0.6× 119 0.7× 47 0.9× 16 0.4× 21 429
Nargiza Parpieva Uzbekistan 11 379 0.7× 261 0.6× 150 0.8× 36 0.7× 13 0.4× 34 425
Frederick Haraka Tanzania 8 442 0.8× 327 0.8× 196 1.1× 56 1.1× 9 0.3× 18 510

Countries citing papers authored by Alberto Piubello

Since Specialization
Citations

This map shows the geographic impact of Alberto Piubello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Piubello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Piubello more than expected).

Fields of papers citing papers by Alberto Piubello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Piubello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Piubello. The network helps show where Alberto Piubello may publish in the future.

Co-authorship network of co-authors of Alberto Piubello

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Piubello. A scholar is included among the top collaborators of Alberto Piubello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Piubello. Alberto Piubello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Souleymane, Mahamadou Bassirou, Tom Decroo, Eric Adéhossi, et al.. (2025). Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB. PubMed. 2(8). 450–458.
2.
Naher, Kamrun, et al.. (2025). Yield of community outreach events for TB screening. The International Journal of Tuberculosis and Lung Disease. 29(6). 285–287.
3.
Jong, Bouke C. de, Achilleas Tsoumanis, Nimer Ortuño‐Gutiérrez, et al.. (2024). Safety of single-dose bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis: A Phase 2 randomized non-inferiority trial in the Comoros Islands. PLoS Medicine. 21(10). e1004453–e1004453. 2 indexed citations
4.
Piubello, Alberto, Achilleas Tsoumanis, Harry van Loen, et al.. (2024). Feasibility and accuracy of mobile QT interval monitoring strategies in bedaquiline‐enhanced prophylactic leprosy treatment. Clinical and Translational Science. 17(8). e13861–e13861. 1 indexed citations
5.
Souleymane, Mahamadou Bassirou, Alberto Piubello, Achilleas Tsoumanis, et al.. (2023). High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin. International Journal of Infectious Diseases. 133. 78–81. 8 indexed citations
6.
7.
Souleymane, Mahamadou Bassirou, Tom Decroo, Saïdou Mamadou, et al.. (2022). Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study. International Health. 15(3). 258–264. 2 indexed citations
8.
Piubello, Alberto, et al.. (2022). Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study. International Journal of Infectious Diseases. 124. 81–88. 5 indexed citations
9.
Dahl, Victor Næstholt, et al.. (2022). Treatment outcomes for multidrug- and rifampicin-resistant tuberculosis in Central and West Africa: a systematic review and meta-analysis. International Journal of Infectious Diseases. 124. S107–S116. 6 indexed citations
10.
11.
Souleymane, Mahamadou Bassirou, Alberto Piubello, Nimer Ortuño‐Gutiérrez, et al.. (2020). High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss. European Respiratory Journal. 57(1). 2002250–2002250. 12 indexed citations
12.
Chiang, Chen‐Yuan, Arnaud Trébucq, Alberto Piubello, et al.. (2020). The looming threat of bedaquiline resistance in tuberculosis. European Respiratory Journal. 55(6). 2000718–2000718. 6 indexed citations
13.
Ejo, Mebrat, Mahamadou Bassirou Souleymane, Pauline Lempens, et al.. (2020). Multidrug-resistant patients receiving treatment in Niger who are infected with M. tuberculosis Cameroon family convert faster in smear and culture than those with M. tuberculosis Ghana family. Tuberculosis. 122. 101922–101922. 6 indexed citations
14.
Schwoebel, V, Arnaud Trébucq, Zacharie Kashongwe, et al.. (2020). Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries. EClinicalMedicine. 20. 100268–100268. 25 indexed citations
15.
Piubello, Alberto, Mahamadou Bassirou Souleymane, Abdourahamane Yacouba, et al.. (2019). Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements. Respiratory Medicine. 161. 105844–105844. 27 indexed citations
16.
Deun, Armand Van, Tom Decroo, Christopher Kuaban, et al.. (2019). Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB. The International Journal of Tuberculosis and Lung Disease. 23(9). 965–971. 21 indexed citations
17.
Deun, Armand Van, Tom Decroo, Alberto Piubello, et al.. (2018). Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs. The International Journal of Tuberculosis and Lung Disease. 22(3). 239–245. 55 indexed citations
18.
Trébucq, Arnaud, V Schwoebel, Zacharie Kashongwe, et al.. (2017). Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries. The International Journal of Tuberculosis and Lung Disease. 22(1). 17–25. 109 indexed citations
19.
Piubello, Alberto, et al.. (2014). High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses. The International Journal of Tuberculosis and Lung Disease. 18(10). 1188–1194. 152 indexed citations
20.
Noeske, J, et al.. (2006). Pulmonary tuberculosis in the central prison of Douala, Cameroon. East African Medical Journal. 83(1). 25–30. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier Padanilam Breakdown of academic impact, for papers by Lorenzo Guglielmetti Breakdown of academic impact, for papers by Anja Reuter Breakdown of academic impact, for papers by Elizabeth Harausz Breakdown of academic impact, for papers by Ronelle Moodliar Breakdown of academic impact, for papers by Carl Reddy Breakdown of academic impact, for papers by Paul Daru Breakdown of academic impact, for papers by Grania Brigden Breakdown of academic impact, for papers by Nargiza Parpieva Breakdown of academic impact, for papers by Frederick Haraka
Rankless by CCL
2026